| | | (Reuters) - General Electric Co said it signed three contracts valued at $2.7 billion with Algeria to supply power generation equipment and turbines to the country's power plants. | | | | | | MILAN (Reuters) - Italy's defense and aerospace group Finmeccanica confirmed to unions at a meeting on Monday it is in advanced talks with Korea-based Doosan Heavy Industries for the sale of its AnsaldoEnergia unit, unions said in a statement. | | | | | | | LONDON (Reuters) - Private equity firm JC Flowers has approached Britain's Lloyds Banking Group about a bid for the TSB business that was split from the part state-owned bank earlier this month, the Sunday Telegraph said without citing sources. | | | | | | | MILAN (Reuters) - Italy would not oppose Air France-KLM increasing its stake in Alitalia to 50 percent, transport minister Maurizio Lupi said on Monday. | | | | | SYDNEY (Reuters) - Toll road operator RiverCity Motorway Ltd, expected to sell for more than A$600 million ($563.22 million), attracted final bids from a group that includes Dutch pension fund manager APG and Australia's Macquarie Group , and separately, the global asset management division of Swiss bank UBS AG , people familiar with the process said. | | | | | (Reuters) - China's Suntech Power Holdings Co Ltd said an Italian court has ruled to seize some solar farms constructed by investees of Global Solar Fund (GSF) controlled by Suntech, accusing GSF of improper operation. | | | | | SEOUL (Reuters) - GS Engineering & Construction Corp said on Monday it won a 1.52 trillion Korean won ($1.4 billion) order for the second phase of constructing petrochemical facilities in Kazakhstan from Kazakhstan LG Poly Ethylene (KLPE) LLP. | | | | | DUESSELDORF, Germany (Reuters) - German steelmaker ThyssenKrupp may walk away from talks over the sale of its Brazil plant, part of its loss-making Steel Americas business, a person familiar with the matter told Reuters on Monday. | | | | SYDNEY (Reuters) - Online foreign exchange services provider OzForex Group plans to raise A$440 million ($413.03 million) by listing on October 11, underscoring positive momentum in Australia's equity market. | | | | BRUSSELS (Reuters) - Belgian biotech firm Ablynx has signed a licensing agreement with U.S. drugmaker AbbVie worth up to $840 million for an experimental drug against rheumatoid arthritis and lupus. | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment